NCT05205161 - A Phase I/II Study of AZD0466 as Monotherapy or in Combination With Anticancer Agents in Advanced Non-Hodgkin Lymphoma | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 5, 2022

Primary Completion Date

August 17, 2023

Study Completion Date

August 17, 2023

Conditions

Non-Hodgkin Lymphoma

Interventions

DRUG

AZD0466

All patients will receive treatment with the investigational product AZD0466 via intravenous infusion.

Trial Locations (10)

Research Site, Heidelberg

Research Site, Milan

Research Site, Pamplona

Research Site, Salamanca

Research Site, Lille

Research Site, Duarte

Research Site, Porto

Research Site, Seoul

Research Site, Seoul

Research Site, Palma de Mallorca